Sonder Capital

Founded in 2019, Sonder Capital is a venture capital firm based in San Carlos, California. It invests in early-stage companies focused on medical devices, diagnostics, and health technology sectors, aiming to transform healthcare by supporting innovative teams and technologies.

Andy McGibbon

Managing Partner

Fred Moll

Managing Partner

Ayo Roberts

Senior Associate

10 past transactions

Neptune Medical

Series D in 2024
Neptune Medical is a venture-capital-backed medical device company focused on gastroenterology. The company develops, manufactures, and commercializes single-use devices designed to enhance the safety, precision, and efficiency of minimally invasive endoscopic procedures. Its products aim to improve patient outcomes by delivering greater control, flexibility, and ease of use for surgeons and clinical teams, with capabilities such as tip control and maneuverability in challenging anatomies, forward advancement and torque of the endoscope, and the ability to maintain an open lumen to swap or reinsert scopes without kinks or luminal collapse. These features help speed procedures, reduce anesthesia time, and improve patient comfort across gastroenterology and related endoscopic applications. Neptune Medical focuses on disposable devices for high-volume clinical settings that streamline workflows while maintaining high safety and performance standards.

Jupiter Endovascular

Series A in 2024
Jupiter Endovascular is a medical technology startup specializing in innovative endovascular procedures. Their flagship product, the Endoportal device, navigates flexibly through blood vessels via minimally invasive percutaneous access. Once positioned, it stabilizes to deliver precise interventional treatments, mimicking the control and precision of direct surgical access but from an endovascular approach. This technology aims to enhance catheter-based interventions by overcoming traditional limitations.

Vitestro

Series A in 2024
Vitestro develops autonomous blood drawing technology aimed at transforming patient care.

Vitestro

Series A in 2023
Vitestro develops autonomous blood drawing technology aimed at transforming patient care.

Wondr Medical

Seed Round in 2022
Wondr Medical is a London-based company established in 2016 that operates a platform designed to connect health professionals worldwide. Its primary objective is to enhance discovery, innovation, and collaboration within the global health network. The platform facilitates the generation of new ideas and the expansion of professional networks, while also aiding in the discovery of medical events and job opportunities. By providing a space for professional teams to share their work and stay informed, Wondr Medical aims to streamline communication and collaboration among medical professionals, ultimately advancing the field of healthcare.

G.I. Windows

Series A in 2020
G.I. Windows, Inc. is a clinical-stage company based in West Bridgewater, Massachusetts, founded in 2012. The company specializes in manufacturing medical devices utilizing advanced surgical anastomotic technology aimed at treating obesity and type 2 diabetes. G.I. Windows is focused on developing innovative solutions that enable less invasive surgical procedures, thereby creating a new category in healthcare. Its technology is designed to enhance the efficiency of diagnostic and interventional procedures, ultimately improving patient outcomes while reducing overall healthcare costs.

Avail Medsystems

Series A in 2020
Avail Medsystems, Inc. is a digital healthcare company based in Palo Alto, California, that specializes in developing a comprehensive hardware and software platform designed to connect healthcare professionals remotely. The company offers a fully integrated audio/visual system that facilitates real-time collaboration and procedural support, enabling practitioners to access clinical expertise and education without the constraints of physical location. By democratizing access to specialized knowledge and services, Avail Medsystems enhances the efficiency of healthcare delivery and promotes the adoption of innovative medical technologies. Founded in 2012 and previously known as Nurep, Inc., the company aims to improve patient care by bridging gaps between healthcare providers and medical technology experts.

BRIUS

Series A in 2020
Mechanodontics, Inc. is a Dallas, Texas-based company established in 2016 that specializes in the manufacture of a discreet dental device designed to move teeth independently. This innovative method serves as an alternative to traditional braces and aligners, offering significant advantages such as reduced treatment time, improved ease of cleaning, and enhanced comfort. The device is placed behind the teeth, making it virtually invisible, and is engineered to work on each tooth individually, allowing for more precise adjustments.

G.I. Windows

Series A in 2019
G.I. Windows, Inc. is a clinical-stage company based in West Bridgewater, Massachusetts, founded in 2012. The company specializes in manufacturing medical devices utilizing advanced surgical anastomotic technology aimed at treating obesity and type 2 diabetes. G.I. Windows is focused on developing innovative solutions that enable less invasive surgical procedures, thereby creating a new category in healthcare. Its technology is designed to enhance the efficiency of diagnostic and interventional procedures, ultimately improving patient outcomes while reducing overall healthcare costs.

Potrero Medical

Series C in 2018
Potrero Medical, Inc. is a predictive health company that specializes in developing advanced monitoring devices to detect subtle changes in physiological parameters. The company's products are designed to provide early warnings of conditions such as sepsis and systemic inflammatory response syndrome, while also optimizing treatment by detecting and preventing fluid overload during resuscitation efforts. Potrero Medical's devices monitor various metrics, including intra-abdominal pressure, core body temperature, heart rate, respiratory rate, relative cardiac output, and urine output. Founded in 2011 and based in San Francisco, California, the company aims to leverage smart sensors and artificial intelligence to enhance the ability of medical teams to predict adverse outcomes in critical care environments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.